ABL Bio Inc. Logo

ABL Bio Inc.

Develops bispecific antibody therapies for oncology and neurodegenerative diseases.

298380 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울 강남구 봉은사로 456 에이비엘바이오빌딩, 강남구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ABL Bio Inc. is a clinical-stage biotechnology company that researches and develops novel antibody therapeutics, primarily focusing on bispecific antibodies. The company's core activities are concentrated in two main therapeutic areas: immuno-oncology and neurodegenerative diseases. For oncology, ABL Bio engineers bispecific antibodies and Antibody-Drug Conjugates (ADCs) designed to enhance anti-tumor immune responses and overcome resistance to existing treatments. In the neurodegenerative field, it utilizes a proprietary platform that enhances the penetration of the blood-brain barrier (BBB) to deliver therapeutics to the central nervous system for diseases like Parkinson's. A pioneer in its field in South Korea, ABL Bio was the first to advance a bispecific antibody platform into clinical trials in the country.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for ABL Bio Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-09 00:00
Share Issue/Capital Change
주식매수선택권행사
Korean 43.5 KB
2025-09-09 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-09-09 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-09-01 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험결과)
Korean 16.4 KB

Automate Your Workflow. Get a real-time feed of all ABL Bio Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ABL Bio Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Sotkamo Silver AB Logo
Mines silver, gold, and zinc in Finland to supply essential metals for green technologies.
Sweden SOSI
Stem Cells Spin Spolka Akcyjna Logo
Biotech firm commercializing proprietary MIC-1 stem cells through R&D, cultivation, and production.
Poland SCS
STRANGER HOLDINGS PLC Logo
Mining and developing uranium and strategic metals with near-term production projects in Africa.
United Kingdom STHP
Ströer SE & Co. KGaA Logo
A media company providing integrated out-of-home (OOH) and digital advertising solutions.
Germany SAX
STUDIO ALICE Co.,Ltd. Logo
Specialized photo studios capturing family milestones with costumes, styling, and kimono rentals.
Japan 2305
Develops digital therapeutics (DTx) and AI systems to streamline clinical development.
Japan 4263
SYNAIRGEN PLC Logo
Developing inhaled interferon beta treatments for severe viral lung infections in hospitalized patients.
United Kingdom SNG
Synerga Fund Spolka Akcyjna Logo
Commercializes medical therapies globally using industrial property and copyrights for clinical use.
Poland SNG
Synergie SE Logo
Offers global HR services, including temporary/permanent recruitment and workforce solutions.
France SDG
SyntekaBio,Inc. Logo
AI drug discovery platform accelerating R&D with supercomputing, SaaS, and pre-made candidates.
South Korea 226330

Talk to a Data Expert

Have a question? We'll get back to you promptly.